Diabetes, Vol 49, Issue 3 450-456, Copyright © 2000 by American Diabetes Association

ARTICLES

Renal glucose production compensates for the liver during the anhepatic phase of liver transplantation

SE Joseph, N Heaton, D Potter, A Pernet, MA Umpleby and SA Amiel
Department of Medicine and Surgery, Guy's, King's and St Thomas' School of Medicine, London, UK. stonnyj@hotmail.com

The extent of the renal contribution to postabsorptive endogenous glucose production (EGP) in humans is controversial. We measured EGP in the absence of the liver during the anhepatic phase (AH) of liver transplantation in five patients (aged 46.4+/-10.2 years, two women). Stable labeling of plasma glucose (PG) was achieved for a 2-h period before the AH by primed continuous infusion of di-deuterated 6,6[2H2]glucose (1.7 mg/min) and continued throughout the AH. PG was maintained above the fasting level (6.1+/-2.73 mmol/l) with 5% dextrose labeled with 6,6[2H2]glucose throughout the AH (mean level during the AH 0.98+/-0.45 mg x kg(-1) x min(-1)). Isotopic enrichment remained stable at 0.84+/-0.21% atom percent excess throughout. EGP, calculated by use of a modified Steele equation, decreased from 2.6+/-1.24 at baseline to 0.97+/-0.9 mg x kg(-1) x min(-1) (36% baseline, P = 0.045) but recovered at approximately 30 min to reach 1.38+/-0.83 mg x kg(-1) x min(-1) (54% baseline) by 60 min. Epinephrine, lactate, free fatty acid, and glycerol levels increased significantly (0.79+/-0.74 to 3.65+/-2.1 nmol/l, P = 0.005; 1.88+/-0.43 to 3.46+/-0.9 mmol/l, P = 0.024; 543.9+/-215.5 to 705.5+/-219.2 micromol/l, P = 0.012; 75.6+/-30.2 to 139+/-96.3 micromol/l, P = 0.003, respectively). These data show that postabsorptive nonhepatic glucose production in humans may contribute to greater than one-third of overall EGP, increasing when required, and that it is associated with a stress response and increased gluconeogenic substrate availability. We conclude that extrahepatic tissues, most notably those of the kidney, make a significant contribution to EGP in humans.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. Battezzati, A. Caumo, F. Martino, L. P. Sereni, J. Coppa, R. Romito, M. Ammatuna, E. Regalia, D. E. Matthews, V. Mazzaferro, et al. Nonhepatic glucose production in humans Am J Physiol Endocrinol Metab, January 1, 2004; 286(1): E129 - E135. [Abstract] [Full Text]

				M. A. Magnuson, P. She, and M. Shiota Gene-altered Mice and Metabolic Flux Control J. Biol. Chem., August 29, 2003; 278(35): 32485 - 32488. [Full Text] [PDF]

				H. J. Woerle, C. Meyer, E. M. Popa, P. E. Cryer, and J. E. Gerich Renal Compensation for Impaired Hepatic Glucose Release During Hypoglycemia in Type 2 Diabetes: Further Evidence for Hepatorenal Reciprocity Diabetes, June 1, 2003; 52(6): 1386 - 1392. [Abstract] [Full Text] [PDF]

				E. Cersosimo, P. Garlick, and J. Ferretti Abnormal Glucose Handling by the Kidney in Response to Hypoglycemia in Type 1 Diabetes Diabetes, September 1, 2001; 50(9): 2087 - 2093. [Abstract] [Full Text] [PDF]

				J. E. Gerich, C. Meyer, H. J. Woerle, and M. Stumvoll Renal Gluconeogenesis: Its importance in human glucose homeostasis Diabetes Care, February 1, 2001; 24(2): 382 - 391. [Abstract] [Full Text]